| Primary |
| Multiple Sclerosis |
42.9% |
| Headache |
21.4% |
| Restless Legs Syndrome |
14.3% |
| Dermatitis Allergic |
7.1% |
| Hypersensitivity |
7.1% |
| Rash Pruritic |
7.1% |
|
| Dyspnoea |
33.3% |
| Muscle Twitching |
33.3% |
| Urticaria |
33.3% |
|
| Secondary |
| Hypertension |
12.1% |
| Product Used For Unknown Indication |
10.4% |
| Fluid Replacement |
7.9% |
| Pain |
7.9% |
| Prophylaxis |
7.9% |
| Thrombosis Prophylaxis |
7.9% |
| Pruritus |
5.4% |
| Anaesthesia |
4.3% |
| Cholangitis |
4.3% |
| Sedation |
4.3% |
| Rash |
3.9% |
| Psoas Abscess |
3.2% |
| Infection |
2.9% |
| Mineral Supplementation |
2.9% |
| Parenteral Nutrition |
2.9% |
| Peptic Ulcer |
2.9% |
| Vomiting |
2.9% |
| Constipation |
2.1% |
| Hepatitis C |
2.1% |
| Multiple Sclerosis |
2.1% |
|
| Toxic Epidermal Necrolysis |
33.3% |
| Renal Failure Acute |
7.7% |
| Stevens-johnson Syndrome |
7.7% |
| Anticholinergic Syndrome |
5.1% |
| Atrial Tachycardia |
5.1% |
| Stomatitis |
5.1% |
| Alcohol Poisoning |
2.6% |
| Asthenia |
2.6% |
| Bradyphrenia |
2.6% |
| Chest Pain |
2.6% |
| Condition Aggravated |
2.6% |
| Death |
2.6% |
| Dysgeusia |
2.6% |
| Dyspnoea |
2.6% |
| Hypertensive Crisis |
2.6% |
| Hypoaesthesia Oral |
2.6% |
| Loss Of Consciousness |
2.6% |
| Maternal Exposure During Pregnancy |
2.6% |
| Muscle Twitching |
2.6% |
| Personality Change |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Premedication |
14.7% |
| Drug Use For Unknown Indication |
11.1% |
| Prophylaxis |
8.4% |
| Hypertension |
6.1% |
| Breast Cancer |
5.7% |
| Pain |
3.7% |
| Colorectal Cancer Metastatic |
2.7% |
| Thrombosis Prophylaxis |
2.3% |
| Non-small Cell Lung Cancer |
2.1% |
| Colon Cancer |
1.8% |
| Diabetes Mellitus |
1.8% |
| Nausea |
1.8% |
| Pruritus |
1.8% |
| Analgesic Therapy |
1.7% |
| Infection |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Hypokalaemia |
1.5% |
| Sleep Disorder |
1.4% |
| Psoas Abscess |
1.3% |
|
| Toxic Epidermal Necrolysis |
11.9% |
| Thrombocytopenia |
9.5% |
| Vomiting |
7.5% |
| Stevens-johnson Syndrome |
7.0% |
| Sepsis |
6.5% |
| General Physical Health Deterioration |
6.0% |
| Pyrexia |
5.5% |
| Headache |
5.0% |
| Renal Failure Acute |
5.0% |
| Infection |
4.5% |
| Swollen Tongue |
4.5% |
| Death |
4.0% |
| Neutropenia |
4.0% |
| Neuromyelitis Optica |
3.0% |
| Peritonitis |
3.0% |
| Pulmonary Oedema |
3.0% |
| Rash Pustular |
3.0% |
| Dyspnoea |
2.5% |
| Leukopenia |
2.5% |
| Lung Infection |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Dementia Alzheimer's Type |
33.3% |
|
|
